Mesoscale Nanoparticles: An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases!

Affiliations

• ¹ From the Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (M.L.Y., X.W., G.A.P., K.P.); Department of Pathology, The University of Melbourne, VIC, Australia (M.L.Y., G.A.P.); Department of Medicine (X.W., K.P.) and Department of Immunology (G.A.P., K.P.), Monash University, Melbourne, VIC, Australia; and Department of Bio-organics and Medicinal Chemistry, Burnet Institute, Melbourne, VIC, Australia (G.A.P.).
• ² From the Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (M.L.Y., X.W., G.A.P., K.P.); Department of Pathology, The University of Melbourne, VIC, Australia (M.L.Y., G.A.P.); Department of Medicine (X.W., K.P.) and Department of Immunology (G.A.P., K.P.), Monash University, Melbourne, VIC, Australia; and Department of Bio-organics and Medicinal Chemistry, Burnet Institute, Melbourne, VIC, Australia (G.A.P.). karlheinz.peter@baker.edu.au.